rheumatology
Research

Tocilizumab trial to start in COVID-19 patients in Queensland

Researchers in Brisbane are to start a randomised controlled trial of tocilizumab as a treatment for patients with severe inflammatory complications of COVID-19 disease. The IL-6 inhibitor already used for cytokine release syndrome in patients receiving CAR T-cell treatment, and will be trialled in COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS). The trial is ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic